文献速递脑血管病

内皮祖细胞增强亚急性卒中血脑屏障通透性

Endothelial progenitor cells enhance blood-brain barrier permeability in subacute stroke.
PubMed 文献 · Neurology · 2017-12-13

研究纳入45例非腔隙性急性缺血性卒中患者(平均年龄70.0±10.0岁),探讨内皮祖细胞(EPC)与亚急性期血脑屏障(BBB)通透性及临床结局的关联。结果显示EPC体外功能特性与第7天BBB通透性相关,第7天BBB通透性独立关联于改善的临床结局(OR 0.897;95%CI 0.816-0.986;p=0.025)。

要点

  • EPC体外功能特性与亚急性期BBB通透性增强相关,尤其第7天
  • 第7天BBB通透性独立关联于3个月良好临床结局
  • 结局良好患者的CD34+ EPC亚群有24个差异表达miRNA,共同影响黏附连接通路

核心结论

  • EPC的功能特性与急性缺血性卒中后亚急性期BBB通透性增强及临床结局改善相关。

研究设计与样本

  • 连续纳入45例大脑中动脉供血区非腔隙性急性缺血性卒中患者,年龄18至80岁。
  • 第0天和第7天行MRI动态对比增强评估BBB通透性,外周血分离EPC并进行迁移和血管生成等功能测试。
  • 临床结局定义为3个月改良Rankin量表评分,统计学显著性设为p<0.05。

主要发现

  • EPC体外功能特性与BBB通透性相关,尤其在第7天。
  • 各EPC亚群数量在两个时间点均与BBB通透性无关联。
  • 第7天BBB通透性独立关联于临床结局改善(OR 0.897;95%CI 0.816-0.986;p=0.025)。
  • 临床结局良好患者的CD34+ EPC亚群显示24个差异表达miRNA,共同影响黏附连接通路。

临床怎么用

  • EPC功能特性及亚急性期BBB通透性可能作为缺血性卒中预后评估的潜在生物学标志。
  • CD34+ EPC的miRNA谱可能为促进卒中后修复提供干预靶点。

局限性

  • 样本量较小(45例),结论需更大样本验证。
  • 未报告卒中严重程度、再灌注治疗等基线特征对结果的潜在影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study the association among endothelial progenitor cells (EPCs), subacute blood-brain barrier (BBB) permeability, and clinical outcome after ischemic stroke, determining the micro RNAs of EPCs responsible for good clinical outcome. METHODS: We included consecutive patients with nonlacunar acute ischemic strokes in the territory of a middle cerebral artery and ages between 18 and 80 years. Clinical outcome was defined as modified Rankin Scale score at 3 months. Neuroimaging was performed at day 0 and 7 by MRI, including assessment of BBB permeability by dynamic contrast enhancement. EPCs were isolated from peripheral venous blood, quantified, and submitted to in vitro functional tests, including migratory and angiogenic assays. Stroke hemodynamics were evaluated serially by ultrasound. Statistical significance was set at p < 0.05. RESULTS: We included 45 patients; mean age was 70.0 ± 10.0 years. The in vitro functional properties of EPCs were associated with BBB permeability, particularly at day 7. The number of each EPC subset at both timepoints was not associated with BBB permeability. Permeability of BBB at day 7 was independently associated with improved clinical outcome (odds ratio 0.897; 95% confidence interval 0.816-0.986; p = 0.025). The EPCs (CD34+ cell subset) of patients with good clinical outcome showed 24 differentially expressed miRNAs, with a common effect on adherens junction pathway. CONCLUSIONS: The functional properties of EPCs are associated with enhanced subacute permeability of BBB and improved clinical outcome after acute ischemic stroke.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Sargento-Freitas J, Aday S, Nunes C, et al. Endothelial progenitor cells enhance blood-brain barrier permeability in subacute stroke. Neurology. 2017. PMID: 29237797. doi:10.1212/WNL.0000000000004801

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。